Home / Health / Novavax says its Covid-19 vaccine gets India authorisation for teens

Novavax says its Covid-19 vaccine gets India authorisation for teens

The authorization is a global first for the age group for the vaccine, which is manufactured and marketed in India by the Serum Institute of India under the brand name Covovax.

FILE - This Wednesday, Oct. 7, 2020 file photo shows a vial of the Phase 3 Novavax coronavirus vaccine ready for use in a trial at St. George's University hospital in London. (Photo: AP)

Premium

FILE PHOTO: Novavax coronavirus vaccine ready for use in a trial at St. George's University hospital in London. (Photo: AP)

Reuters

1 min read Last Updated : Mar 24 2022 | 12:45 AM IST

Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.

The authorization is a global first for the age group for the vaccine, which is manufactured and marketed in India by the Serum Institute of India under the brand name Covovax.

Novavax last month said its vaccine was 80% effective against COVID-19 in a late-stage trial testing the shot in 2,247 teens aged 12 to 17 years.

The company said on Tuesday its vaccine produced an immune response in the same age group in a mid- to

Disclaimer: No Business Standard Journalist was involved in creation of this content

Topics : Coronavirus Coronavirus Tests Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in